Obesity may account for up to one in four polypharmacy cases
The study reveals obesity’s role in polypharmacy, indicating that reducing obesity may lower medication burden and enhance quality of life for older adults.
The study reveals obesity’s role in polypharmacy, indicating that reducing obesity may lower medication burden and enhance quality of life for older adults.